Contents

Current Angiogenesis (Discontinued), Volume 3 - Number 4

Editorial

Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)

, 3(4): 175 - 178

Samir A. Farghaly


DOI: 10.2174/221155280304150825115417




Novel Therapeutic Strategies For Angiogenesis Inhibition In Recurrent Ovarian Cancer

, 3(4): 179 - 192

Victoria L. Chiou, Elise C. Kohn, Nicole Davarpanah and Jung-Min Lee


DOI: 10.2174/221155280304150825115555




Trebananib (AMG 386): A Non-VEGF Antiangiogenesis Option in Women with Ovarian Cancer

, 3(4): 193 - 202

Al Wadi Khalid and Ghatage Prafull


DOI: 10.2174/2211552804666150331222508




Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer

, 3(4): 203 - 214

Simone Ten Kortenaar, Jack Lawler and Jim Petrik


DOI: 10.2174/2211552804666150310233900




Ovarian Cancer - Angiogenesis and Targeted Therapy

, 3(4): 215 - 230

Kristsanamon Rittiluechai, Naiyarat Prasongsuk, Vincent Vinh-Hung and Claire Verschraegen


DOI: 10.2174/2211552804666150213211810




VEGF/VEGFR2 Autocrine Signaling Stimulates Metastasis in Prostate Cancer Cells

, 3(4): 231 - 244

Matthew Migliozzi, Yasuhiro Hida, Meetu Seth, Graham Brown, Joanne Kwan, Silvia Coma, Dipak Panigrahy, Rosalyn M. Adam, Jacqueline Banyard, Akio Shimizu and Diane R. Bielenberg


DOI: 10.2174/221155280304150825120419




Quantization of Angiogenesis and Image Analysis

, 3(4): 245 - 249

Nikolaos Kavantzas, Vasileios Salpeas, Eleftheria Lakiotaki and Petros M. Pavlopoulos


DOI: 10.2174/2211552802666140104000902




Acknowledgements to the Reviewers:

, 3(4): 250


DOI: 10.2174/221155280304150825120645




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science